Vital Chemtech Grants 2,32,300 ESOPs Under Scheme-2025
Vital Chemtech Limited granted 2,32,300 ESOPs to employees under its Scheme-2025. The options have a face value of ₹10 and were granted at ₹10 each. Vesting occurs between 1-3 years, with a 60-day exercise window post-vesting.
The grant of ESOPs is a common corporate practice for employee incentives and typically has a minimal direct financial impact on the company's stock price in the short term.
The announcement is a routine grant of employee stock options, which is a standard practice and does not inherently indicate positive or negative performance.
Vital Chemtech Limited announced that its Nomination and Remuneration Committee, in a meeting held on March 24, 2026, granted 2,32,300 equity stock options (ESOPs) to eligible employees under the Vital Employee Stock Option Scheme-2025.
The meeting commenced at 02:15 p.m. and concluded at 02:50 p.m. on the same day. Each ESOP has a face value of ₹10 and was granted at a price of ₹10 per option.
The ESOPs are formulated and approved by shareholders in accordance with the SEBI (Share Based Employee Benefits) Regulations, 2021. The grant covers 2,32,300 Equity Shares of ₹10 each, with each option granting the right to apply for one equity share.
The minimum vesting period for these options is one year, with a maximum vesting period of three years from the grant date. The exercise period can commence from the vesting date and Grantees can exercise vested options within 60 days from the closure of the vesting period, subject to the Nomination and Remuneration Committee's determination.
What to do with a filing like this
Vital Chemtech Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Vital Chemtech Limited. Read the original for the full detail.